Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Butyrate Ingredient BIOMEnd Had Superior Pharmacokinetic Performance Over Other Butyrate: Study - Nutraceuticals World

What are you searching for?

Sign in
Research

Butyrate Ingredient BIOMEnd Had Superior Pharmacokinetic Performance Over Other Butyrate: Study

Compared to tributyrin and sodium butyrate, NutraShure’s lysine butyrate ingredient showed greater serum butyrate concentrations and time to maximum concentration.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Sevendeman | Adobe Stock

A butyrate ingredient marketed as BIOMEnd by NutraShure was associated with greater pharmacokinetic performance and subjective self-reported measures of well-being, in a clinical study published in the Journal of Exercise and Nutrition.

The study included a group of 10 healthy adult men between the ages of 25 and 45 who ingested one of three butyrate forms, with blood samples and assessments collected over a 3.5-hour post-ingestion period. Measurements included serum butyrate concentrations, feelings of well-being, and physiological vitals. Blood samples were collected at six time points and analyzed using GC-MS (gas chromatography-mass spectrometry) techniques to measure serum butyrate levels. The researchers also measured participants’ self-reported mood, motivation, and concentration via Visual Analog Scale questionnaires.

BIOMEnd had significantly higher peak plasma concentrations (Cmax) and a quicker time to maximum concentration (Tmax) compared to tributyrin, indicating greater bioavailability and faster systemic circulation. The small group of participants also reported greater feelings of well-being, calmness, and motivation after ingesting BIOMEnd. BIOMEnd achieved a 500% greater Cmax than tributyrin and a 180% greater Cmax than sodium butyrate.

“This study is the first comparative study of three commercially available forms of butyrate,” said Brandon Sojka, CEO of NutraShure. “The exceptional pharmacokinetic advantage of BIOMEnd, coupled with our new substantiated GLP-1 claims and superior delivery form, allows us to provide a truly innovative solution for supporting gut health, weight management, and overall well-being.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics